Pharmacokinetic Studies for Medications Development


NIH 2000 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco
NIH 1999 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco
NIH 1998 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco
NIH 1998 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco
NIH 1997 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco
NIH 1996 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco
NIH 1995 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco
NIH 1994 N01 DA	Pharmacokinetic Studies for Medications Development Jones, Reese T. / University of California San Francisco
NIH 1994 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco
NIH 1994 N01 DA	Pharmacokinetic and Pharmacodynamic Studies Jones, Reese T. / University of California San Francisco

Ciraulo, Domenic A; Hitzemann, Robert J; Somoza, Eugene et al. (2006) Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials. J Clin Pharmacol 46:179-92

Houtsmuller, Elisabeth J; Notes, Lisa D; Newton, Thomas et al. (2004) Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology (Berl) 172:31-40

Uemura, Naoto; Nath, Rajneesh P; Harkey, Martha R et al. (2004) Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. J Anal Toxicol 28:253-9